{
    "organizations": [],
    "uuid": "3425bdad116f0136894b83ffdb825973df1741e9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mayne-pharma-group-posts-h1-loss-a/brief-mayne-pharma-group-posts-h1-loss-attributable-of-174-2-mln-idUSFWN1QC1AF",
    "ord_in_thread": 0,
    "title": "BRIEF-Mayne Pharma Group Posts H1 Loss Attributable Of $174.2 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Mayne Pharma Group Ltd:\n* ‍HY REVENUE FROM ORDINARY ACTIVITIES $243.3 MILLION VERSUS $294.8 MILLION\n* ‍HY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE $174.2 MILLION VERSUS PROFIT OF $72.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T06:57:00.000+02:00",
    "crawled": "2018-02-23T15:49:56.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mayne",
        "pharma",
        "group",
        "ltd",
        "revenue",
        "ordinary",
        "activity",
        "million",
        "versus",
        "million",
        "loss",
        "ordinary",
        "activity",
        "attributable",
        "million",
        "versus",
        "profit",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}